发明授权
US08623828B2 Blocking mesothelin peptide fragments 失效
阻断间皮素肽片段

Blocking mesothelin peptide fragments
摘要:
The present invention provides mesothelin peptide fragments corresponding to the CA125 binding site of mesothelin. The peptide fragments find use in disrupting the binding interaction between mesothelin and CA 125, for example, in the treatment and prevention of cancers that require the interaction of mesothelin and CA125 for growth, progression and/or metastasis.
公开/授权文献
信息查询
0/0